These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A Mixed Presentation of Serotonin Syndrome Versus Neuroleptic Malignant Syndrome in a 12-Year-Old Boy. Ott M; Werneke U Pediatr Emerg Care; 2019 May; 35(5):e98. PubMed ID: 30964850 [No Abstract] [Full Text] [Related]
4. Distinguishing between Neuroleptic Malignant Syndrome and Serotonin Syndrome in Polypharmacy: An Overview with a Case Report. Debeljak T; Kores Plesničar B Psychiatr Danub; 2021; 33(Suppl 4):1227-1229. PubMed ID: 35354191 [No Abstract] [Full Text] [Related]
6. Serotonin syndrome versus neuroleptic malignant syndrome: a case report. Fernández M; Lago L; Alonso MG; Guede A; Benavente JL; Olivares JM Actas Esp Psiquiatr; 2018 Mar; 46(2):68-74. PubMed ID: 29616715 [No Abstract] [Full Text] [Related]
7. Understanding toxidromes: serotonin toxicity: a commentary on Montanes-Rada et al. Gillman PK J Clin Psychopharmacol; 2005 Dec; 25(6):625-6. PubMed ID: 16282860 [No Abstract] [Full Text] [Related]
8. Serotonin syndrome: not a benign toxidrome. Garside S; Rosebush PI CMAJ; 2003 Sep; 169(6):543. PubMed ID: 12975218 [No Abstract] [Full Text] [Related]
9. Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary. Dosi R; Ambaliya A; Joshi H; Patell R BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24957740 [TBL] [Abstract][Full Text] [Related]
10. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management. Perry PJ; Wilborn CA Ann Clin Psychiatry; 2012 May; 24(2):155-62. PubMed ID: 22563571 [TBL] [Abstract][Full Text] [Related]
11. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool. Sokoro AA; Zivot J; Ariano RE Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660 [TBL] [Abstract][Full Text] [Related]
13. Comment: Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool. Darracq MA Ann Pharmacother; 2012 Apr; 46(4):611-2; author reply 613. PubMed ID: 22414789 [No Abstract] [Full Text] [Related]
14. Comment: Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool. Sanaei-Zadeh H Ann Pharmacother; 2012 Apr; 46(4):612; author reply 613. PubMed ID: 22414792 [No Abstract] [Full Text] [Related]
15. A diagnostic confusion between Serotonin syndrome and Neuroleptic malignant syndrome. Prakash S Am J Emerg Med; 2021 May; 43():272-273. PubMed ID: 33008703 [No Abstract] [Full Text] [Related]
16. Case files of the program in medical toxicology at brown university: amantadine withdrawal and the neuroleptic malignant syndrome. Brantley E; Cohn J; Babu K J Med Toxicol; 2009 Jun; 5(2):92-8. PubMed ID: 19415596 [No Abstract] [Full Text] [Related]
17. The authors' response: A diagnostic confusion between serotonin syndrome and neuroleptic malignant syndrome. Soh M; Hifumi T; Isokawa S; Shimizu M; Otani N; Ishimatsu S Am J Emerg Med; 2021 May; 43():274. PubMed ID: 32622686 [No Abstract] [Full Text] [Related]
19. The neuroleptic malignant and serotonin syndromes. Carbone JR Emerg Med Clin North Am; 2000 May; 18(2):317-25, x. PubMed ID: 10767887 [TBL] [Abstract][Full Text] [Related]